333 related articles for article (PubMed ID: 20140221)
1. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
[TBL] [Abstract][Full Text] [Related]
2. [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
[TBL] [Abstract][Full Text] [Related]
3. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer.
He Q; Chen HY; Bai EQ; Luo YX; Fu RJ; He YS; Jiang J; Wang HQ
Cancer Genet Cytogenet; 2010 Oct; 202(1):1-10. PubMed ID: 20804913
[TBL] [Abstract][Full Text] [Related]
4. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
Li Y; Li B; Jiang R; Liao L; Zheng C; Yuan J; Zeng L; Hu K; Zhang Y; Mei W; Hong Z; Xiao B; Kong L; Han K; Tang J; Jiang W; Pan Z; Zhang S; Ding P
Cancer Med; 2023 Nov; 12(21):20626-20638. PubMed ID: 37881109
[TBL] [Abstract][Full Text] [Related]
5. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
6. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
Huang ZH; Li LH; Yang F; Wang JF
World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
[TBL] [Abstract][Full Text] [Related]
7. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
[TBL] [Abstract][Full Text] [Related]
8. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
9. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
10. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
[TBL] [Abstract][Full Text] [Related]
11. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.
Grützmann R; Molnar B; Pilarsky C; Habermann JK; Schlag PM; Saeger HD; Miehlke S; Stolz T; Model F; Roblick UJ; Bruch HP; Koch R; Liebenberg V; Devos T; Song X; Day RH; Sledziewski AZ; Lofton-Day C
PLoS One; 2008; 3(11):e3759. PubMed ID: 19018278
[TBL] [Abstract][Full Text] [Related]
13. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.
Ebert MP; Model F; Mooney S; Hale K; Lograsso J; Tonnes-Priddy L; Hoffmann J; Csepregi A; Röcken C; Molnar B; Schulz HU; Malfertheiner P; Lofton-Day C
Gastroenterology; 2006 Nov; 131(5):1418-30. PubMed ID: 17101318
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
15. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal cancer in urine using DNA methylation analysis.
Bach S; Paulis I; Sluiter NR; Tibbesma M; Martin I; van de Wiel MA; Tuynman JB; Bahce I; Kazemier G; Steenbergen RDM
Sci Rep; 2021 Jan; 11(1):2363. PubMed ID: 33504902
[TBL] [Abstract][Full Text] [Related]
17. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
[TBL] [Abstract][Full Text] [Related]
18. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.
Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ
J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329
[TBL] [Abstract][Full Text] [Related]
19. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
